IDXX

IDEXX Laboratories, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-20

Figures on this page computed 2026-11-08 12:33 UTC

Last close

698.55USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-02-20

51.3xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- computed
- 10-K for 2025, filed 2026-02-20
The filing itself
54.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
The filing itself
24.6%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
The filing itself
24.6%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-K for 2025, filed 2026-02-20
The filing itself
0.36Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
- 10-K for 2025, filed 2026-02-20
- 10-Q for 2025, filed 2026-11-02
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Price is the furthest below its sector's middle: 0.09 against 0.36 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

All from 100

lens 2 of 9

Sales

242

2016-12-31 to 2025-12-31100 at the start242

Sales: 100.00 on 2016-12-31 to 242.40 on 2025-12-31, up 142%.

Profit

477

2016-12-31 to 2025-12-31100 at the start477

Profit: 100.00 on 2016-12-31 to 477.14 on 2025-12-31, up 377%.

Shares in issue

89.2

2016-12-31 to 2025-12-31100 at the start89.2

Shares in issue: 100.00 on 2016-12-31 to 89.15 on 2025-12-31, down 11%.

Sales is at 242, Profit is at 477, Shares in issue is at 89, against 100 in 2016.

Sales is at 242, Profit is at 477, Shares in issue is at 89, against 100 in 2016.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-02-20

Sales, where the first year is 100242
Source
filed
Statement
income
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
The filing itself
Profit, where the first year is 100477
Source
filed
Statement
income
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
The filing itself
Shares in issue, where the first year is 10089
Source
filed
Statement
income
Fiscal year
2025
Accession
0000874716-26-000038
Reported in
USD
The filing itself